J3245 – Injection, tildrakizumab, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ3245
- Long description
- Injection, tildrakizumab, 1 mg
- Short description
- Inj., tildrakizumab, 1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2019
- Last change
- January 1, 2019 – No change
Frequently asked questions
What is HCPCS code J3245?
J3245 is a HCPCS Level II code for injection, tildrakizumab, 1 mg.
Does Medicare cover J3245?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J3140 – Injection, testosterone suspension, up to 50 mg
- J3145 – Injection, testosterone undecanoate, 1 mg
- J3150 – Injection, testosterone propionate, up to 100 mg
- J3230 – Injection, chlorpromazine hcl, up to 50 mg
- J3240 – Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
- J3241 – Injection, teprotumumab-trbw, 10 mg
- J3243 – Injection, tigecycline, 1 mg
- J3244 – Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3246 – Injection, tirofiban hcl, 0.25 mg
- J3247 – Injection, secukinumab, intravenous, 1 mg
- J3250 – Injection, trimethobenzamide hcl, up to 200 mg
- J3260 – Injection, tobramycin sulfate, up to 80 mg
- J3262 – Injection, tocilizumab, 1 mg
- J3263 – Injection, toripalimab-tpzi, 1 mg
- J3265 – Injection, torsemide, 10 mg/ml
- J3268 – Injection, delafloxacin, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.